Treating chikungunya using HIV/AIDS drug efavirenz
Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...
Fierce Biotech9d
Immunocore T-cell engager clears safety hurdle, reduces HIV reservoir in some patients
Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...
The Mail & Guardian6d
The endgame to HIV/Aids
The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...
allAfrica.com on MSN5d
How much does our HIV response depend on US funding?
In the wake of US funding cuts for global aid, numerous donor-funded health facilities in South Africa have shut down and ...
Aidsmap3d
Broadly neutralising antibody N6LS could be part of long-acting HIV treatment
People living with HIV normally produce HIV-specific antibodies, but these mostly target parts of the virus that are hidden or highly variable. However, a small proportion of people naturally make ...
The New Times on MSN11d
Africa: Solutions to TB and HIV Benefit All of Us, North and South
Guest Column - In the west of Kenya, near the shores of Lake Victoria, where I come from, a tuberculosis outbreak is no ...
NBC News on MSN7d
Measles is unlike other viruses: What to know about long-term complications
Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops ...